These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6217353)

  • 1. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
    Weitekamp MR; Aber RC
    JAMA; 1983 Jan; 249(1):69-71. PubMed ID: 6217353
    [No Abstract]   [Full Text] [Related]  

  • 2. Moxalactam-associated platelet dysfunction.
    Slonaker CE; Luper WE
    JAMA; 1983 Aug; 250(6):729-30. PubMed ID: 6224031
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged bleeding time associated with moxalactam administration.
    Fishman L; Marsh WR
    Neurosurgery; 1984 Jun; 14(6):735-6. PubMed ID: 6462409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy associated with the use of moxalactam.
    Pakter RL; Russell TR; Mielke CH; West D
    JAMA; 1982 Sep; 248(9):1100. PubMed ID: 6213792
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of moxalactam on blood coagulation and platelet function.
    Bang NU; Tessler SS; Heidenreich RO; Marks CA; Mattler LE
    Rev Infect Dis; 1982; 4 Suppl():S546-54. PubMed ID: 6218565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterococcal infections in patients treated with moxalactam.
    Moellering RC
    Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam.
    Panwalker AP; Rosenfeld J
    J Infect Dis; 1983 Jan; 147(1):171-2. PubMed ID: 6218209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acquired coagulopathy caused by administration of parenteral broad-spectrum antibiotics].
    Kikuchi S; Ando A; Minato K
    Rinsho Byori; 1991 Jan; 39(1):83-90. PubMed ID: 1901116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy associated with moxalactam.
    Lee S; Spira S; Gabor EP
    JAMA; 1983 Apr; 249(15):2019-20. PubMed ID: 6220163
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of cefmetazole and latamoxef on platelet function in healthy human volunteers.
    Peters GR; Metzler CM
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():119-23. PubMed ID: 2722718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxalactam, bleeding, and renal insufficiency.
    D'Elia JA; Kaldany A; Miller DG; Yoburn DC; Kaye WA
    JAMA; 1983 Mar; 249(12):1565. PubMed ID: 6219234
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxalactam-induced coagulopathy.
    Jensen BC
    Clin Pharm; 1983; 2(4):301-2. PubMed ID: 6224629
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding disorders associated with newer cephalosporins.
    Quintiliani R
    Clin Pharm; 1983; 2(4):360-1. PubMed ID: 6224630
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of Haemophilus influenzae infection and moxalactam on platelet function in children.
    Kaplan SL; Courtney JT; Kenal KA
    Antimicrob Agents Chemother; 1987 Mar; 31(3):467-9. PubMed ID: 3579263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding problems.
    Childs SJ
    Arch Intern Med; 1983 Jan; 143(1):183-4. PubMed ID: 6217791
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibiotic-associated colitis during moxalactam therapy.
    Tofte RW
    J Antimicrob Chemother; 1981 Apr; 7(4):445-6. PubMed ID: 6454676
    [No Abstract]   [Full Text] [Related]  

  • 18. [Moxalactam in complications of abdominal surgery].
    Dupeyron JP; Peter JD; Rigolot JC
    Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New beta-lactam antibiotics and hemorrhagic diathesis: comparison of moxalactam and cefotaxime.
    Andrassy K; Koderisch J; Fritz S; Ritz E
    Clin Ther; 1983; 6(1):34-42. PubMed ID: 6325005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.